Renhuang Announces Fiscal Year 2010 Guidance
Expects 26% to 28% revenue and net income growth HARBIN, China, March 4 /PRNewswire-Asia/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medic...
Renhuang Reports Record Fiscal 2009 Results; Resumes Compliance With SEC Filing Requirements
HARBIN, China, Feb. 8 /PRNewswire-Asia/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheet: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), announced today that it has filed its annual...
Renhuang Pharmaceuticals, Inc. Engages New Independent Auditor
HARBIN, China, Jan. 20 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) (“Renhuang” or “the Company”), a leading pharmaceutical company in the People’s Republic of China (“PRC”), today announced that it has engaged Moore Stephens, P.C. (“MSPC”) as its new indepe...
Renhuang Pharmaceuticals, Inc.'s Laboratory Recognized by Heilongjiang Science and Technology Institute
HARBIN, China, July 1 /Xinhua-PRNewswire-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or "the Company"), a leading pharmaceutical company in the People's Republic of China ("PRC"), today announced that its wholly-owned Traditional Chinese Medicine Extract and ...
Renhuang Pharmaceuticals, Inc. Holds Trade Show for Tianma Pills; Signs Letters of Intent
HARBIN, China, June 6 /Xinhua-PRNewswire/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or "the Company"), a leading pharmaceutical company in the People's Republic of China ("PRC"), today announced the successful completion of its Tianma pills trade show in Harbin, China on ...
Renhuang Pharmaceuticals, Inc. Announces Solid Fourth Quarter and Fiscal Year 2007 Results
HARBIN, China, May 30 /Xinhua-PRNewswire/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) (“Renhuang” or “the Company”), a leading pharmaceutical company in the People’s Republic of China (“PRC”), today reported solid financial results for the fourth quarter and fiscal year ended October 3...
Renhuang Pharmaceuticals, Inc. Attended the Heilongjiang Biology Industry Development Fair
HARBIN, China, May 21 /Xinhua-PRNewswire/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) (“Renhuang” or “the Company”), a leading pharmaceutical company in the People’s Republic of China (“PRC”), today announced its successful participation in the Heilongjiang Biology Industry Develop...
Renhuang Pharmaceuticals, Inc. Co-Sponsors Sino-German Workshop on Sleep Research
HARBIN, China, May 16 /Xinhua-PRNewswire-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or "the Company"), a leading pharmaceutical company in the People's Republic of China ("PRC"), today announced its participation as a co-sponsor of the first Sino-German Wo...
Renhuang Pharmaceuticals, Inc. Attended the 103rd China Import and Export Fair
HARBIN, China, April 29 /Xinhua-PRNewswire-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or "the Company"), a leading pharmaceutical company in the People's Republic of China ("PRC"), today announced its successful participation in the 103rd China Import and Expo...
